Literature DB >> 28756605

Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies.

Stojan Peric1, Ruzica Maksimovic2, Bojan Banko2, Milica Durdic2, Bogdan Bjelica1, Ivo Bozovic1, Yunus Balcik1, Jovan Pesovic3, Dusanka Savic-Pavicevic3, Vidosava Rakocevic-Stojanovic4.   

Abstract

Magnetic resonance imaging (MRI) of muscles has recently become a significant diagnostic procedure in neuromuscular disorders. There is a lack of muscle MRI studies in patients with myotonic dystrophy type 1 (DM1), especially type 2 (DM2). To analyze fatty infiltration of leg muscles, using 3.0 T MRI in patients with genetically confirmed DM1 and DM2 with different disease durations. The study comprised 21 DM1 and 10 DM2 adult patients. Muscle MRI was performed in axial plane of the lower limbs using T1-weighted (T1w) sequence. Six-point scale by Mercuri et al. was used. Fatty infiltration registered in at least one muscle of lower extremities was found in 71% of DM1 and 40% of DM2 patients. In DM1 patients, early involvement of the medial head of gastrocnemius and tibialis anterior muscles was observed with later involvement of other lower leg muscles and of anterior and posterior thigh compartments with relative sparing of the rectus femoris. In DM2, majority of patients had normal MRI findings. Early involvement of lower legs and posterior thighs was found in some patients. Less severe involvement of the medial head of the gastrocnemius compared to other lower leg muscles was also observed, while involvement of proximal muscles was rather diffuse than selective. It seems that both in DM1 and DM2 some muscles may be affected before weakness is clinically noted and vice versa. We described characteristic pattern and way of progression of muscle involvement in DM1 and DM2.

Entities:  

Keywords:  Fatty infiltration; Legs; Muscle magnetic resonance imaging; Myotonic dystrophy type 1; Myotonic dystrophy type 2; Progression

Mesh:

Year:  2017        PMID: 28756605     DOI: 10.1007/s00415-017-8574-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Muscle MRI in myotonic dystrophy type 1 with foot drop.

Authors:  Tadanori Hamano; Yasutaka Kawamura; Tatsuro Mutoh; Mikio Hirayama; Masaru Kuriyama
Journal:  Eur Neurol       Date:  2010-02-05       Impact factor: 1.710

2.  TREAT-NMD workshop: pattern recognition in genetic muscle diseases using muscle MRI: 25-26 February 2011, Rome, Italy.

Authors:  Volker Straub; Pierre G Carlier; Eugenio Mercuri
Journal:  Neuromuscul Disord       Date:  2012-10-01       Impact factor: 4.296

3.  Chronic neurogenic quadriceps amyotrophies.

Authors:  G Serratrice; A Pou-Serradel; J F Pellissier; H Roux; J Lamarco-Civro; J Pouget
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

4.  MRI of tibialis anterior skeletal muscle in myotonic dystrophy type 1.

Authors:  Chantal Coté; Bassem Hiba; Luc J Hebert; Christophe Vial; Jean François Remec; Marc Janier; Jack Puymirat
Journal:  Can J Neurol Sci       Date:  2011-01       Impact factor: 2.104

5.  Variability of multisystemic features in myotonic dystrophy type 1--lessons from Serbian registry.

Authors:  Vidosava Rakocevic-Stojanovic; Stojan Peric; Ivana Basta; Valerija Dobricic; Vesna Ralic; Aleksandra Kacar; Marina Peric; Ivana Novakovic
Journal:  Neurol Res       Date:  2015-07-17       Impact factor: 2.448

6.  Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy.

Authors:  J Mathieu; H Boivin; D Meunier; M Gaudreault; P Bégin
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

7.  Magnetic resonance imaging of muscles in myotonic dystrophy.

Authors:  J Castillo; J M Pumar; J R Rodríguez; J M Prieto; L Arrojo; F Martínez; M Noya
Journal:  Eur J Radiol       Date:  1993-11       Impact factor: 3.528

8.  Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.

Authors:  Tiina Suominen; Linda L Bachinski; Satu Auvinen; Peter Hackman; Keith A Baggerly; Corrado Angelini; Leena Peltonen; Ralf Krahe; Bjarne Udd
Journal:  Eur J Hum Genet       Date:  2011-03-02       Impact factor: 4.246

9.  Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.

Authors:  Erik-Jan Kamsteeg; Wolfram Kress; Claudio Catalli; Jens M Hertz; Martina Witsch-Baumgartner; Michael F Buckley; Baziel G M van Engelen; Marianne Schwartz; Hans Scheffer
Journal:  Eur J Hum Genet       Date:  2012-05-30       Impact factor: 4.246

Review 10.  Neuromuscular imaging in inherited muscle diseases.

Authors:  Mike P Wattjes; Rudolf A Kley; Dirk Fischer
Journal:  Eur Radiol       Date:  2010-04-27       Impact factor: 5.315

View more
  5 in total

Review 1.  MR imaging of inherited myopathies: a review and proposal of imaging algorithms.

Authors:  Laís Uyeda Aivazoglou; Julio Brandão Guimarães; Thomas M Link; Maria Alice Freitas Costa; Fabiano Nassar Cardoso; Bruno de Mattos Lombardi Badia; Igor Braga Farias; Wladimir Bocca Vieira de Rezende Pinto; Paulo Victor Sgobbi de Souza; Acary Souza Bulle Oliveira; Alzira Alves de Siqueira Carvalho; André Yui Aihara; Artur da Rocha Corrêa Fernandes
Journal:  Eur Radiol       Date:  2021-04-21       Impact factor: 5.315

2.  Quantitative muscle MRI as a sensitive marker of early muscle pathology in myotonic dystrophy type 1.

Authors:  Ellen van der Plas; Laurie Gutmann; Dan Thedens; Richard K Shields; Kathleen Langbehn; Zhihui Guo; Milan Sonka; Peggy Nopoulos
Journal:  Muscle Nerve       Date:  2021-02-05       Impact factor: 3.217

3.  Lower extremity muscle pathology in myotonic dystrophy type 1 assessed by quantitative MRI.

Authors:  Linda Heskamp; Marlies van Nimwegen; Marieke J Ploegmakers; Guillaume Bassez; Jean-Francois Deux; Sarah A Cumming; Darren G Monckton; Baziel G M van Engelen; Arend Heerschap
Journal:  Neurology       Date:  2019-05-22       Impact factor: 9.910

4.  Modeling muscle regeneration in RNA toxicity mice.

Authors:  Ramesh S Yadava; Mahua Mandal; Jack M Giese; Frank Rigo; C Frank Bennett; Mani S Mahadevan
Journal:  Hum Mol Genet       Date:  2021-06-09       Impact factor: 6.150

5.  Autoimmune Diseases in Patients With Myotonic Dystrophy Type 2.

Authors:  Stojan Peric; Jelena Zlatar; Luka Nikolic; Vukan Ivanovic; Jovan Pesovic; Ivana Petrovic Djordjevic; Svetlana Sreckovic; Dusanka Savic-Pavicevic; Giovanni Meola; Vidosava Rakocevic-Stojanovic
Journal:  Front Neurol       Date:  2022-07-18       Impact factor: 4.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.